Manickavasagar U, Nel H, Seet J, Varrone L, Keehner T, McCann R
Open Forum Infect Dis. 2025; 12(2):ofaf070.
PMID: 39990633
PMC: 11843442.
DOI: 10.1093/ofid/ofaf070.
Kluemper A, Morris K, Mellon M
Bladder (San Franc). 2025; 11(4):e21200022.
PMID: 39944512
PMC: 11810682.
DOI: 10.14440/bladder.2024.0035.
Das S, Lavine K
Curr Cardiol Rep. 2025; 27(1):18.
PMID: 39804563
DOI: 10.1007/s11886-024-02167-7.
Zhao X, Qi X, Liu D, Che X, Wu G
Int J Nanomedicine. 2024; 19:13461-13483.
PMID: 39713223
PMC: 11662911.
DOI: 10.2147/IJN.S498729.
Huang J, Lin L, Mao D, Hua R, Guan F
Front Immunol. 2024; 15:1464635.
PMID: 39507536
PMC: 11538002.
DOI: 10.3389/fimmu.2024.1464635.
The Impact of Dose Reduction of Bacillus Calmette-Guerin on Oncological Outcomes and Toxicity in Non-Muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
Azuri W, Jaunarena J, Camean J, Chemi J, Villaronga A, Daneshmand S
Bladder Cancer. 2024; 9(3):227-236.
PMID: 38993181
PMC: 11181759.
DOI: 10.3233/BLC-230044.
Research progress on the microbiota in bladder cancer tumors.
Lou K, Chi J, Wu J, Ma J, Liu S, Cui Y
Front Cell Infect Microbiol. 2024; 14:1374944.
PMID: 38650736
PMC: 11033431.
DOI: 10.3389/fcimb.2024.1374944.
Bladder Cancer: Immunotherapy and Pelvic Lymph Node Dissection.
Fan Z, Deng J, Wang Y, Fan X, Xie J
Vaccines (Basel). 2024; 12(2).
PMID: 38400134
PMC: 10893107.
DOI: 10.3390/vaccines12020150.
BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer.
Lidagoster S, Ben-David R, De Leon B, Sfakianos J
Curr Oncol. 2024; 31(2):1063-1078.
PMID: 38392073
PMC: 10888316.
DOI: 10.3390/curroncol31020079.
expression as a potential prognostic biomarker for risk stratification of T1 high grade bladder cancer: Unveiling the aggressive nature of a distinct non-muscle invasive subtype.
Kim K, Byun Y, Zheng C, Moon S, Jo S, Kang H
Investig Clin Urol. 2024; 65(1):94-103.
PMID: 38197756
PMC: 10789541.
DOI: 10.4111/icu.20230227.
Granulomatous myocarditis arising from intravesical Bacillus Calmette-Guérin therapy leading to death diagnosed by postmortem examination: a case report.
Geetha S, Chavarria H, Abdelwahed M, Kataria N, Bijol V, Das K
J Med Case Rep. 2024; 18(1):12.
PMID: 38195538
PMC: 10777644.
DOI: 10.1186/s13256-023-04310-4.
Targeted therapies in bladder cancer: signaling pathways, applications, and challenges.
Peng M, Chu X, Peng Y, Li D, Zhang Z, Wang W
MedComm (2020). 2023; 4(6):e455.
PMID: 38107059
PMC: 10724512.
DOI: 10.1002/mco2.455.
Effects of intravenous chemotherapy after TURBT for high-risk nonmuscle invasive bladder cancer: results of a retrospective study.
Chen J, Zhang Z, Nie Z, Qiu J
J Cancer Res Clin Oncol. 2023; 149(15):13905-13913.
PMID: 37540255
DOI: 10.1007/s00432-023-05206-y.
Multiparametric magnetic resonance imaging for the differential diagnosis between granulomatous prostatitis and prostate cancer: a literature review to an intriguing diagnostic challenge.
Gaudiano C, Renzetti B, De Fino C, Corcioni B, Ciccarese F, Bianchi L
Front Oncol. 2023; 13:1178430.
PMID: 37342186
PMC: 10277616.
DOI: 10.3389/fonc.2023.1178430.
Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers.
Zhang H, Liu L, Liu J, Dang P, Hu S, Yuan W
Mol Cancer. 2023; 22(1):58.
PMID: 36941614
PMC: 10029244.
DOI: 10.1186/s12943-023-01725-x.
Tuberculous spondylitis following intravesical Bacillus Calmette-Guérin therapy for bladder cancer surgically treated through the anterior approach.
Shimizu T, Kobayashi Y, Fujiyoshi K, Yato Y
BMJ Case Rep. 2023; 15(12).
PMID: 36593635
PMC: 9743316.
DOI: 10.1136/bcr-2022-251075.
The global research of bladder cancer immunotherapy from 2012 to 2021: A bibliometric analysis.
Qiu Q, Deng C, Li H, Qiu J, Shen Z, Ding Y
Front Oncol. 2022; 12:999203.
PMID: 36452503
PMC: 9703076.
DOI: 10.3389/fonc.2022.999203.
Development and Validation of a Prognostic Nomogram for Predicting Overall Survival for T1 High-Grade Patients After Radical Cystectomy: A Study Based on SEER.
Zhan X, Chen L, Jiang M, Fu B
Int J Gen Med. 2022; 15:3753-3765.
PMID: 35411173
PMC: 8994665.
DOI: 10.2147/IJGM.S354740.
Perioperative immunotherapy in muscle-invasive bladder cancer.
Lee H, Ham W
Transl Cancer Res. 2022; 9(10):6546-6553.
PMID: 35117264
PMC: 8799279.
DOI: 10.21037/tcr.2020.01.36.
Role of immunotherapy in Bacillus Calmette-Guérin unresponsive: non-muscle invasive bladder cancer.
Suh J, Yoo S
Transl Cancer Res. 2022; 9(10):6537-6545.
PMID: 35117263
PMC: 8799067.
DOI: 10.21037/tcr-20-758.
